Cabot Corp. (CBT) Financial Ratios

Cabot Corp. (CBT) has an ST Score of 57.1 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Analysts rate CBT a Buy, with a price target of $94.00 (+19.5% vs the current price). Our ST Score grades it B- (57.1/100). The ST Score is a data-driven signal, not a recommendation.

Valuation C+, Profitability A, Financial Strength C+, Momentum C+, Growth B-, Forecast B-.

Cabot Corp. (CBT) earns a valuation grade of C+, measured against Chemicals - Specialty peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

Cabot Corp. (CBT) earns a growth grade of B-, measured against Chemicals - Specialty peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

Cabot Corp. (CBT) earns a profitability grade of A, measured against Chemicals - Specialty peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

Cabot Corp. (CBT) earns a financial strength grade of C+, measured against Chemicals - Specialty peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

The average analyst price target for Cabot Corp. (CBT) is $94.00 from 15 analysts, which is +19.5% versus the recent price of $78.65.

Cabot Corp. (CBT) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.